Benjamin Ory
- Cancer Research top 2%
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 5
- Oncology top 2%
- Cancer-related Molecular Pathways 9
- Bone health and treatments 9
- Molecular Biology top 5%
- RNA modifications and cancer 9
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 6
-
- Sarcoma Diagnosis and Treatment 9
- Rheumatology top 5%
- Co-authors
- Dominique HeymannFrançoise RédiníFrançois LamoureuxMarie‐Françoise HeymannMarc Baud’huinLeif W. EllisenMarta Tellez GabrielLidia Rodriguez Calleja
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Benjamin Ory
58 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 709
- Oncology 1.0k
- Molecular Biology 1.4k
- Pulmonary and Respiratory Medicine 611
- Rheumatology 207
Countries citing papers authored by Benjamin Ory
This map shows the geographic impact of Benjamin Ory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Ory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Ory more than expected).
Fields of papers citing papers by Benjamin Ory
This network shows the impact of papers produced by Benjamin Ory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Ory. The network helps show where Benjamin Ory may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Benjamin Ory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2021 | 25 | |
| 5 | 2020 | 85 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 30 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 3 | |
| 10 | 2016 | 43 | |
| 11 | 2016 | 47 | |
| 12 | 2015 | 28 | |
| 13 | 2014 | 110 | |
| 14 | 2011 | 89 | |
| 15 | 2011 | 36 | |
| 16 | 2011 | 45 | |
| 17 | 2010 | 74 | |
| 18 | 2010 | 30 | |
| 19 | 2008 | 27 | |
| 20 | 2006 | 87 |
About Benjamin Ory
Benjamin Ory is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 60 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related Molecular Pathways (9 papers), Bone health and treatments (9 papers), Sarcoma Diagnosis and Treatment (9 papers), RNA modifications and cancer (9 papers), Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (6 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (709 citations), Oncology (1.0k citations) and Molecular Biology (1.4k citations). Benjamin Ory has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Dominique Heymann, Françoise Rédiní, François Lamoureux, Marie‐Françoise Heymann, Marc Baud’huin, Leif W. Ellisen, Marta Tellez Gabriel, Lidia Rodriguez Calleja, Céline Charrier and Frédéric Blanchard. Their work appears in journals such as Cancers, Oncotarget, Cells, Cancer Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.